Phase I study of VR647 in patients with Asthma

Trial Profile

Phase I study of VR647 in patients with Asthma

Planning
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2017

At a glance

  • Drugs Budesonide (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Jan 2017 According to a Vectura media release, this study is expected to initiate in H1 2017.
    • 24 Jan 2017 According to a Vectura media release, company has received an Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) to conduct this study.
    • 22 Nov 2016 According to a Vectura Group plc media release, the IND filing is anticipated by the end of 2106.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top